Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01160211
Title A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements Yes
Sponsors GlaxoSmithKline
Indications

Her2-receptor positive breast cancer

Therapies

Lapatinib + Trastuzumab

Letrozole

Anastrozole

Lapatinib

Trastuzumab

Exemestane

Age Groups: adult | senior
Covered Countries USA | ITA | GBR | FRA | ESP | DEU | CAN | BEL | AUS

Additional content available in CKB BOOST